The Accumulation Distribution reference data for Terns Pharmaceuticals is derived from the equity's published trading history. The resulting forecast and deviation statistics are presented as reference data for informational context. Forecast values and accuracy statistics are presented for informational purposes. All values shown are derived from publicly available market data.
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume The forecast reference data presented here for Terns Pharmaceuticals reflects Accumulation Distribution model output and is intended as reference material for analytical use.
Accumulation Distribution Analysis Today
Terns Pharmaceuticals has current Accumulation Distribution of 598591.0. The accumulation distribution (A/D) indicator shows the degree to which Terns Pharmaceuticals is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Terns Pharmaceuticals to determine if accumulation or reduction is taking place in the market. This value is adjusted by Terns Pharmaceuticals trading volume to give more weight to distributions with higher volume over lower volume.
On March 25 2026 Terns Pharmaceuticals was traded for 52.86 at the closing time. The top price for the day was 52.98 and the lowest listed price was 52.59 . The trading volume for the day was 81.3 M. The trading history from March 25, 2026 did not result in any price rise and fall. The trading price change against the current closing price is -0.44% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Other Forecasting Options for Terns Pharmaceuticals
Fibonacci retracement levels applied to Terns Stock price swings identify potential support and resistance zones. Extreme price moves in Terns occur more frequently than standard risk models assume. Support and resistance levels derived from Terns Pharmaceuticals' historical data identify zones where buying or selling pressure has stalled moves. A volume spike without a corresponding price move can signal accumulation or distribution ahead of a directional breakout.
Terns Pharmaceuticals's market space within the Health Care space is best grasped by looking at the firms listed below. Looking at Terns Pharmaceuticals' pricing multiples next to these peers shows if the stock trades at a premium or discount. Peer review is most useful when paired with absolute pricing and trend checks.
Tracking market strength indicators for Terns Pharmaceuticals provides context for understanding stock momentum dynamics. Tracking these indicators helps identify periods where trading Terns Pharmaceuticals is likely to be most rewarding. These tools are essential for timing trades in Terns Pharmaceuticals with a quantitative framework. Market strength indicators for Terns Pharmaceuticals are most useful when viewed as part of a broader analytical framework.
Properly assessing Terns Pharmaceuticals' risk indicators is a prerequisite for building reliable price forecasts. This analysis provides context for determining the appropriate level of risk to accept when holding Terns Pharmaceuticals'. Analyzing Terns Pharmaceuticals' risk indicators provides a critical input for investment risk management. By quantifying the risk in Terns Pharmaceuticals' investment, investors can make more informed decisions about hedging strategies.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Terns Pharmaceuticals
Coverage intensity for Terns Pharmaceuticals matters because narrative visibility can influence sentiment, participation, and volatility around the name. A disciplined read of coverage separates durable relevance from temporary noise.
Reviewing short-oriented indicators for Terns Pharmaceuticals is useful because long and short participants often create very different signals for timing and volatility. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
Common Stock Shares Outstanding
79.5 M
Cash And Short Term Investments
358.2 M
More Resources for Terns Stock Analysis
A baseline understanding of Terns Pharmaceuticals is formed through its financial statements and trends. These metrics are based on Terns Pharmaceuticals' reported financial results.
